Comparison of Alpinia officinarum Hance and placebo on spermogram test
- Conditions
- Sperm disorders.Disorder of male genital organs, unspecified
- Registration Number
- IRCT2016103130616N1
- Lead Sponsor
- Vice chancellor for research, Babol University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- Male
- Target Recruitment
- 60
Inclusion criteria : idiopathic oligospermia disorder; idiopathic Teratospermic disorder; idiopathic Asthenospermia disorder
azoospermia; Pretesticular disorder such as endocrine disorders (hyperprolactinemia, congenital adrenal hyperplasia, ...); Chromosomal disorders such as Klinefelter, men XX, XYY; known Testicular dysfunction such as varicocele or orchitis or Cryptorchidism; Post testicular dysfunction such as the mechanical obstruction, impaired embryo transfer or functional obstruction, vasectomy and; A history of treatment for infertility in the past three month; Medication history affecting semen; History of anti-metabolite drugs ;Diabetics patients; Hypo-and hyperthyroidism patients; History of chemotherapy; A history of cerebrovascular diseases ; A history of exposure to radiation or radioactive radiation
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Sperm motility. Timepoint: Before the treatment & Three months after taking the drug and placebo. Method of measurement: spermogram.;Sperm morphology. Timepoint: Before the treatment & Three months after taking the drug and placebo. Method of measurement: spermogram.;Sperm Count. Timepoint: Before the treatment& Three months after taking the drug and placebo. Method of measurement: spermogram.;Sperm volume. Timepoint: Before the treatment. Method of measurement: spermogram.
- Secondary Outcome Measures
Name Time Method Volume of semen. Timepoint: Three months after taking the drug and placebo. Method of measurement: spermogram.;Sperm Count. Timepoint: Three months after taking the drug and placebo. Method of measurement: spermogram.;Sperm motility. Timepoint: Three months after taking the drug and placebo. Method of measurement: spermogram.;Sperm morphology. Timepoint: Three months after taking the drug and placebo. Method of measurement: spermogram.